XTX Topco »

4d Molecular Therapeutics In shares owned by XTX Topco

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by XTX Topco from 13F filings

Historical chart of XTX Topco investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by XTX Topco consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by XTX Topco

Quarter filed Position value Share count Share price at filing
2025-12-31 $488k 65k 7.50
2025-09-30 $348k 40k 8.69
2025-06-30 $292k 79k 3.71
2024-12-31 $206k 37k 5.57
2022-06-30 $139k 20k 6.97

More positions owned by XTX Topco

Procter & Gamble Company (PG)
JPMorgan Chase & Co. (JPM)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Cme (CME)
Kroger (KR)
At&t (T)
Vanguard Index Fds Total Stk Mkt (VTI)
Metropcs Communications (TMUS)
First Ctzns Bancshares Inc D Cl A (FCNCA)
S&p Global (SPGI)
Albertsons Cos Common Stock (ACI)
O'reilly Automotive (ORLY)
Owl Rock Capital Corporation (OBDC)

View all positions for XTX Topco

Top funds holding 4d Molecular Therapeutics In

BVF
RA Capital Management
Goldman Sachs Group
BlackRock
Novo A/S
Vanguard Group
State Street Corporation
Henderson Group
Federated Investors
Point72 Asset Management
Millennium Management
Armistice Capital
Geode Capital Management
Evergreen Quality Fund GP
Deutsche Bank Aktiengesellschaft

View all funds holding 4d Molecular Therapeutics In